Neurofibromatosis type 1 (NF1) is a genetic condition that affects the skin, nervous system, and other parts of the body. The condition, formerly called Von Recklinghausen disease, causes changes in ...
SPRINT: Phase II study of the MEK 1/2 inhibitor selumetinib (AZD6244, ARRY-142886) in children with neurofibromatosis type 1 (NF1) and inoperable plexiform neurofibromas (PN). This is an ASCO Meeting ...
Neurofibromatosis type 1 is an autosomal dominant disorder that affects multiple organ systems and has a wide range of variable clinical manifestations. It is one of three conditions described under ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results